Comparison between mupirocin and other drugs as gentamicin for preventing peritoneal dialysis related infections

ZHANG Xiao-qun,ZHANG Wei,SHOU Zhang-fei,HE Qiang
2013-01-01
Abstract:Objective To find out whether there are drugs as effective as mupirocin for prevention of exit-site infection(ESI) and peritonitis in peritoneal dialysis(PD) patients,thus providing more choices for preventing infection clinically.Methods MEDLINE,the Cochrane Database,EMBASE and the Science Citation Index were searched for randomized controlled trials(RCTs) or self controlled studies that met the inclusion criteria.Comparisons between mupirocin and other drugs in prevention of ESI and peritonitis were done.Results Six studies involving a total of 537 patients versus 532 controls were included in the analysis.The overall ESI rates,the total peritonitis rates and the rates of peritonitis due to S.aureus were similar in the two groups(P = 0.28,P = 0.06,P = 0.31).However,mupirocin decreased the risk by 47%(95% CI: 0.10-0.69) in ESI due to S.aureus.Analyses on subgroups of mupirocin and gentamin groups indicated the same results,and the total ESI rates,the peritonitis rates and the rates of peritonitis due to S.aureus were similar in the two subgroups(P = 0.87,P = 0.21,P = 0.53).But mupirocin decreased the risk by 63%(95% CI: 0.23-0.82) in ESI due to S.aureus.Conclusion No superior drugs are found in preventing total ESI and PD related peritonitis in patients.But in preventing ESI due to S.aureus,mupirocin is superior to other drugs.Clinically,mupirocin is still recommended as the optimal preventive drug.
What problem does this paper attempt to address?